Literature DB >> 16494579

Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.

Olivier Joubert1, Gabriella Viero, Daniel Keller, Eric Martinez, Didier A Colin, Henri Monteil, Lionel Mourey, Mauro Dalla Serra, Gilles Prévost.   

Abstract

The staphylococcal alpha-toxin and bipartite leucotoxins belong to a single family of pore-forming toxins that are rich in beta-strands, although the stoichiometry and electrophysiological characteristics of their pores are different. The different known structures show a common beta-sandwich domain that plays a key role in subunit-subunit interactions, which could be targeted to inhibit oligomerization of these toxins. We used several cysteine mutants of both HlgA (gamma-haemolysin A) and HlgB (gamma-haemolysin B) to challenge 20 heterodimers linked by disulphide bridges. A new strategy was developed in order to obtain a good yield for S-S bond formation and dimer stabilization. Functions of the pores formed by 14 purified dimers were investigated on model membranes, i.e. planar lipid bilayers and large unilamellar vesicles, and on target cells, i.e. rabbit and human red blood cells and polymorphonuclear neutrophils. We observed that dimers HlgA T28C-HlgB N156C and HlgA T21C-HlgB T157C form pores with similar characteristics as the wild-type toxin, thus suggesting that the mutated residues are facing one another, allowing pore formation. Our results also confirm the octameric stoichiometry of the leucotoxin pores, as well as the parity of the two monomers in the pore. Correctly assembled heterodimers thus constitute the minimal functional unit of leucotoxins. We propose amino acids involved in interactions at one of the two interfaces for an assembled leucotoxin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494579      PMCID: PMC1462717          DOI: 10.1042/BJ20051878

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Monomer-monomer interactions drive the prepore to pore conversion of a beta-barrel-forming cholesterol-dependent cytolysin.

Authors:  Eileen M Hotze; Alejandro P Heuck; Daniel M Czajkowsky; Zhifeng Shao; Arthur E Johnson; Rodney K Tweten
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

2.  Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore.

Authors:  George Miles; Liviu Movileanu; Hagan Bayley
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

3.  Retrieving biological activity from LukF-PV mutants combined with different S components implies compatibility between the stem domains of these staphylococcal bicomponent leucotoxins.

Authors:  S Werner; D A Colin; M Coraiola; G Menestrina; H Monteil; G Prévost
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Stochastic assembly of two-component staphylococcal gamma-hemolysin into heteroheptameric transmembrane pores with alternate subunit arrangements in ratios of 3:4 and 4:3.

Authors:  Noriko Sugawara-Tomita; Toshio Tomita; Yoshiyuki Kamio
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

5.  Protein engineering modulates the transport properties and ion selectivity of the pores formed by staphylococcal gamma-haemolysins in lipid membranes.

Authors:  Massimiliano Comai; Mauro Dalla Serra; Manuela Coraiola; Sandra Werner; Didier A Colin; Henri Monteil; Gilles Prévost; Gianfranco Menestrina
Journal:  Mol Microbiol       Date:  2002-06       Impact factor: 3.501

6.  Partial C-terminal unfolding is required for channel formation by staphylococcal alpha-toxin.

Authors:  B Vécsey-Semjén; R Möllby; F G van der Goot
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

7.  Flow cytometric determination of Panton-Valentine leucocidin S component binding.

Authors:  V Gauduchon; S Werner; G Prévost; H Monteil; D A Colin
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Discoupling the Ca(2+)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs.

Authors:  L Baba Moussa; S Werner; D A Colin; L Mourey; J D Pédelacq; J P Samama; A Sanni; H Monteil; G Prévost
Journal:  FEBS Lett       Date:  1999-11-19       Impact factor: 4.124

9.  Mechanism of membrane permeabilization by sticholysin I, a cytolysin isolated from the venom of the sea anemone Stichodactyla helianthus.

Authors:  M Tejuca; M D Serra; M Ferreras; M E Lanio; G Menestrina
Journal:  Biochemistry       Date:  1996-11-26       Impact factor: 3.162

10.  Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification.

Authors:  B Walker; H Bayley
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

View more
  11 in total

1.  Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components.

Authors:  Keitaro Yamashita; Yuka Kawai; Yoshikazu Tanaka; Nagisa Hirano; Jun Kaneko; Noriko Tomita; Makoto Ohta; Yoshiyuki Kamio; Min Yao; Isao Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

2.  Crystallization and preliminary crystallographic studies of both components of the staphylococcal LukE-LukD leukotoxin.

Authors:  Romain Galy; Fabien Bergeret; Daniel Keller; Lionel Mourey; Gilles Prévost; Laurent Maveyraud
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

Review 3.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

Review 4.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

5.  Distinction between pore assembly by staphylococcal alpha-toxin versus leukotoxins.

Authors:  Olivier Joubert; Joëlle Voegelin; Valérie Guillet; Samuel Tranier; Sandra Werner; Didier A Colin; Mauro Dalla Serra; Daniel Keller; Henri Monteil; Lionel Mourey; Gilles Prévost
Journal:  J Biomed Biotechnol       Date:  2007-02-28

6.  Above and beyond C5a Receptor Targeting by Staphylococcal Leucotoxins: Retrograde Transport of Panton-Valentine Leucocidin and γ-Hemolysin.

Authors:  Gaëlle Zimmermann-Meisse; Gilles Prévost; Emmanuel Jover
Journal:  Toxins (Basel)       Date:  2017-01-20       Impact factor: 4.546

7.  Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2.

Authors:  Dan Zhang; Peiman Shooshtarizadeh; Benoît-Joseph Laventie; Didier André Colin; Jean-François Chich; Jasmina Vidic; Jean de Barry; Sylvette Chasserot-Golaz; François Delalande; Alain Van Dorsselaer; Francis Schneider; Karen Helle; Dominique Aunis; Gilles Prévost; Marie-Hélène Metz-Boutigue
Journal:  PLoS One       Date:  2009-02-19       Impact factor: 3.240

8.  Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.

Authors:  Rajan P Adhikari; Thomas Kort; Sergey Shulenin; Tulasikumari Kanipakala; Nader Ganjbaksh; Mary-Claire Roghmann; Frederick W Holtsberg; M Javad Aman
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 9.  Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy.

Authors:  M Javad Aman; Rajan P Adhikari
Journal:  Toxins (Basel)       Date:  2014-03-04       Impact factor: 4.546

10.  Residues essential for Panton-Valentine leukocidin S component binding to its cell receptor suggest both plasticity and adaptability in its interaction surface.

Authors:  Benoit-Joseph Laventie; Frédéric Guérin; Lionel Mourey; Mira Y Tawk; Emmanuel Jover; Laurent Maveyraud; Gilles Prévost
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.